All news

Barclays starts ABT at Overweight with

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

Barclays initiated coverage on Abbott Laboratories (ABT) with an Overweight rating and a

Read original source

ABT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.